WHO grade II meningioma: a retrospective study for outcome and prognostic factor assessment.
about
Overall survival benefit associated with adjuvant radiotherapy in WHO grade II meningioma.Stereotactic radiotherapy as primary definitive or postoperative treatment of intracranial meningioma of WHO grade II and III leads to better disease control than stereotactic radiotherapy of recurrent meningioma.High-precision radiotherapy for meningiomas : Long-term results and patient-reported outcome (PRO).Recurrence pattern analysis after [68Ga]-DOTATATE-PET/CT -planned radiotherapy of high-grade meningiomas.
P2860
WHO grade II meningioma: a retrospective study for outcome and prognostic factor assessment.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
WHO grade II meningioma: a ret ...... prognostic factor assessment.
@en
WHO grade II meningioma: a ret ...... prognostic factor assessment.
@nl
type
label
WHO grade II meningioma: a ret ...... prognostic factor assessment.
@en
WHO grade II meningioma: a ret ...... prognostic factor assessment.
@nl
prefLabel
WHO grade II meningioma: a ret ...... prognostic factor assessment.
@en
WHO grade II meningioma: a ret ...... prognostic factor assessment.
@nl
P2093
P2860
P1476
WHO grade II meningioma: a ret ...... d prognostic factor assessment
@en
P2093
Akbar Ali Khan
Charles Champeaux
Colin Shieff
Elena Wilson
P2860
P2888
P304
P356
10.1007/S11060-016-2181-2
P50
P577
2016-06-16T00:00:00Z